BRPI0215775A2 - substância do fármaco azul de toluidina o (toluidine blue o) e aplicação do mesmo para tingimento in vivo e tratamento quimioterápico de tecidos displásicos. - Google Patents

substância do fármaco azul de toluidina o (toluidine blue o) e aplicação do mesmo para tingimento in vivo e tratamento quimioterápico de tecidos displásicos.

Info

Publication number
BRPI0215775A2
BRPI0215775A2 BRPI0215775A BR0215775A BRPI0215775A2 BR PI0215775 A2 BRPI0215775 A2 BR PI0215775A2 BR PI0215775 A BRPI0215775 A BR PI0215775A BR 0215775 A BR0215775 A BR 0215775A BR PI0215775 A2 BRPI0215775 A2 BR PI0215775A2
Authority
BR
Brazil
Prior art keywords
toluidine blue
dyeing
vivo
substance
application
Prior art date
Application number
BRPI0215775A
Other languages
English (en)
Inventor
Karl Okolotowicz
Original Assignee
Zila Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zila Inc filed Critical Zila Inc
Publication of BRPI0215775A2 publication Critical patent/BRPI0215775A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B21/00—Thiazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
BRPI0215775A 2002-06-04 2002-06-04 substância do fármaco azul de toluidina o (toluidine blue o) e aplicação do mesmo para tingimento in vivo e tratamento quimioterápico de tecidos displásicos. BRPI0215775A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/017720 WO2003103569A2 (en) 2002-06-04 2002-06-04 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues

Publications (1)

Publication Number Publication Date
BRPI0215775A2 true BRPI0215775A2 (pt) 2016-07-05

Family

ID=29731309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0215775A BRPI0215775A2 (pt) 2002-06-04 2002-06-04 substância do fármaco azul de toluidina o (toluidine blue o) e aplicação do mesmo para tingimento in vivo e tratamento quimioterápico de tecidos displásicos.

Country Status (9)

Country Link
EP (1) EP1534346A4 (pt)
JP (1) JP2005535605A (pt)
CN (1) CN1302815C (pt)
AU (1) AU2002312319A1 (pt)
BR (1) BRPI0215775A2 (pt)
IL (1) IL165516A0 (pt)
MX (1) MXPA04012031A (pt)
TW (1) TW200733956A (pt)
WO (1) WO2003103569A2 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH071257B2 (ja) * 1985-09-09 1995-01-11 エスエス製薬株式会社 混合ビタミン剤中の水溶性ビタミン類の同時定量法
JPS6410171A (en) * 1987-07-03 1989-01-13 Shimadzu Corp Analysis of amino acid
CA2097695C (en) * 1991-10-31 2000-08-08 Mark J. Malmros Biological stain composition, method of preparation and method of use for delineation of epithelial cancer
WO1999025388A1 (en) * 1997-11-13 1999-05-27 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
US6086852A (en) * 1997-11-13 2000-07-11 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
US6194573B1 (en) * 1997-11-13 2001-02-27 Zila, Inc. Process for manufacture of in vivo stain composition
WO2001064110A1 (en) * 2000-02-28 2001-09-07 Zila, Inc. Method for detecting and killing epithelial cancer cells
JP4424838B2 (ja) * 2000-08-31 2010-03-03 株式会社トクヤマ 四級アンモニウム塩の分析方法

Also Published As

Publication number Publication date
AU2002312319A1 (en) 2003-12-22
TW200733956A (en) 2007-09-16
CN1627961A (zh) 2005-06-15
EP1534346A2 (en) 2005-06-01
MXPA04012031A (es) 2005-03-07
EP1534346A4 (en) 2007-07-25
WO2003103569A3 (en) 2004-05-21
JP2005535605A (ja) 2005-11-24
WO2003103569A2 (en) 2003-12-18
CN1302815C (zh) 2007-03-07
IL165516A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
DE602004022946D1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
EE200200321A (et) Lähi-infrapunafluorestsentskontrastaine ja fluorestsentskuvamine
DE60230591D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DE60237580D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
IL189019A0 (en) Pdt (photodynamic therapy) treatment method for cellulites and cosmetic use
MXPA03008969A (es) Nueva composicion tintorea para tinte de fibras queratinicas que comprende colorante diazoico dicationico particular.
IS6965A (is) Ganglíósíð-tengd raðbrigða mótefni og notkun þeirra í sjúkdómsgreiningu og meðferð á æxlum
EP1551990A4 (en) DIAGNOSIS AND TREATMENT OF CHEMOSTORED TUMORS
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
SI2308975T1 (sl) Molekule protitelesa, ki imajo specifičnost za človeške tumorje nekrotizirajoči faktor alfa, in uporabe le-teh
DE60305037D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
IL163900A (en) Antibody which binds to tpte for use in diagnosing, monitoring, preventing or treating cancer disease and pharmaceutical compositions comprising said antibody
DE60324431D1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata- oder gebahrmutterkrebs
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EE200100416A (et) Hargneva ahelaga aminohappe-sõltuvad aminotransferaasinhibiitorid ja nende kasutamine diabeetilise retinopaatia ravis
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
DE60107034D1 (de) Misch- und Ladeöffnung zur medizinischen Behandlung
PL373346A1 (en) Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
AU2003263036A8 (en) Span-xb gene and protein for the diagnosis and treatment of cancer
IL165516A0 (en) Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues
ATE420074T1 (de) Bengamide-derivate und deren verwendung zur behandlung von krebserkrankungen
BR0308976A (pt) Terapia combinada contra tumores compreendendo derivados de acriloil distamicina substituìda e radioterapia
MX250033B (es) Composicion de coloracion para materias queratinicas humanas consistente en un colorante fluorescente y un polimero asociativo, procedimiento y uso.

Legal Events

Date Code Title Description
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: ANULACAO DA PUBLICACAO CODIGO 6.7 NA RPI NO 2132 DE 16/11/2011, POR TER SIDO INDEVIDA

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 10A, 11A, 12A, 13A E 14A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]